To further determine whether ZEB1-induced loss of ER-α caused antiestrogen resistance in breast cancer cells, ZEB1/MCF-7 or shZEB1/231 cells were treated with tamoxifen, and cell viability was measured. Here, ESR1 is linked to breast carcinoma.